Mice lacking the transcriptional repressor oncoprotein Gfi1 are unexpectedly neutropenic 1,2 . We therefore screened GFI1 as a candidate for association with neutropenia in affected individuals without mutations in ELA2 (encoding neutrophil elastase), the most common cause of severe congenital neutropenia (SCN; ref. 3). We found dominant negative zinc finger mutations that disable transcriptional repressor activity. The phenotype also includes immunodeficient lymphocytes and production of a circulating population of myeloid cells that appear immature. We show by chromatin immunoprecipitation, gel shift, reporter assays and elevated expression of ELA2 in vivo in neutropenic individuals that GFI1 represses ELA2, linking these two genes in a common pathway involved in myeloid differentiation.
Mice lacking the transcriptional repressor oncoprotein Gfi1 are unexpectedly neutropenic 1,2 . We therefore screened GFI1 as a candidate for association with neutropenia in affected individuals without mutations in ELA2 (encoding neutrophil elastase), the most common cause of severe congenital neutropenia (SCN; ref. 3 ). We found dominant negative zinc finger mutations that disable transcriptional repressor activity. The phenotype also includes immunodeficient lymphocytes and production of a circulating population of myeloid cells that appear immature. We show by chromatin immunoprecipitation, gel shift, reporter assays and elevated expression of ELA2 in vivo in neutropenic individuals that GFI1 represses ELA2, linking these two genes in a common pathway involved in myeloid differentiation.
Low neutrophil numbers lead to opportunistic infections. There are two hereditary human neutropenia syndromes: cyclic hematopoiesis 4 , comprising three-week oscillations of blood cells, and SCN 3 , consisting of statically low neutrophil counts progressing to leukemia. Heterozygous mutations of ELA2 cause cyclic hematopoiesis and about two-thirds of SCN cases. Mutations in WAS (different from those that cause Wiskott-Aldrich thrombocytopenia) also cause SCN 5 . Owing to its severity, SCN usually arises from new mutations, and additional genes associated with neutropenia have not yet been identified.
Gfi1 encodes a zinc finger transcriptional repressor oncoprotein identified in a retroviral insertion mutagenesis screen for tumor progression to interleukin-2-independent growth 6 . Gene targeting showed that Gfi1-deficient mice were unexpectedly neutropenic 1, 2 . We therefore screened 105 unrelated neutropenic probands who did not have mutations in ELA2: 49 individuals with SCN and 56 with nonimmune chronic idiopathic neutropenia of adults (NI-CINA; ref. 7) , incorporating cases of milder neutropenia diagnosed as an adult but also predisposing to leukemia.
Sequencing of genomic DNA identified two probands with alterations in the GFI1 coding sequence. We identified a heterozygous 1412A→G transition (Fig. 1a) causing a N382S substitution in the fifth zinc finger (Fig. 1b) in a four-month-old boy with SCN who had a neutrophil count of zero and marked monocytosis (2,756 µl -1 ). The mutation segregated with his three-year-old paternal half-brother, who is identically affected, and with their father, who had recurrent pneumonia and pyogenic abscesses abating during childhood. The father's childhood blood counts are not accessible, but at age 27, his neutrophils number 900 µl -1 and monocytes 1,200 µl -1 (by automated counting). His peripheral blood shows a population of myeloid cells that appear immature (Fig. 1c) . The myeloid, but not erythroid, colony formation potential of his cultured peripheral blood is lower than normal; non-erythroid colonies had intact differentiation to monocytes or macrophages but had an excess of myeloid precursors with no mature neutrophils (Fig. 1d) . Flow cytometric analysis of his peripheral blood confirmed there were fewer neutrophils and more CD45 + CD33 + CD11b + cells than in a normal adult (Fig. 1e) . We observed a reduction in absolute cell numbers of CD4 T lymphocytes (from 1,186 to 624 T cells µl -1 ) and especially naive CD3 + CD4 + T lymphocytes (from 379 to 78 naive CD4 T cells µl -1 ). CD62L + CD45RA + stains identified fewer naive CD4 T cells ( Fig. 1e ; from 32.5% to 17.4%) with confirmation by CD27 + CCR7 + staining (data not shown). Moreover, B lymphocytes were also reduced ( Fig. 1e ; from 6.2% to 3.5%). Peripheral blood lymphocytes from both the father and the older son showed similar trends, and both had poor 3 Hthymidine uptake after stimulation with phytohemagglutinin, alloantigen and Candida albicans compared with normal subjects. The child, however, had adequate circulating titers to immunizations, and all immunoglobulin isotypes were present in his serum (data not shown), indicating that, though reduced in number and activation potential, the T and B lymphocyte populations were functional.
We identified a second mutation in a 66-year-old woman with NI-CINA, who was heterozygous with respect to a 1475A→G transition in GFI1 (Fig. 1a) causing the amino acid substitution K403R in the sixth zinc finger (Fig. 1b) . She was found to be neutropenic ten years earlier, and since then she has had persistently low neutrophil number (<1,700 µl -1 ) and elevated monocytes (>600 µl -1 ). Analysis for acquired causes has proven negative, including drug exposures and autoimmune serologies (antibodies against nuclear antigens, against double-stranded DNA, against polymorphonuclear leukocytes and against rheumatoid factors). She is not known to have ever had a normal blood count. There is no known history of infectious complications. She lacks other living family.
These amino acid substitutions are probably important, given that Asn382 and Lys403 are identical in Gfi1 homologs in divergent species and are conserved in the paralog Gfi1b (Fig. 1b) . No GFI1 coding sequence alterations were indentified in 76 control chromosomes; further sequencing of the final exon, containing both 1412A→G and 1475A→G, found no other sequence changes among 484 control chromosomes.
The phenotypes of individuals with mutations in GFI1 and of Gfi1-knockout mice are similar with respect to responsiveness to granulocyte colony-stimulating factor (G-CSF), monocytosis, lymphopenia and appearance of abnormal blood cells with features of both immature neutrophils and monocytes. Complete deletion of Gfi1 results in runting and inner ear defects in the mouse model 8 , but humans with amino acid substitutions show no evidence of these or other developmental problems. The combined neutropenia and immunodeficiency resembles the WHIM syndrome of myelokathexis 9 , but the undifferentiated appearance of the neutrophils differs from the hypermature appearance of neutrophils in WHIM syndrome.
In contrast to gene-targeted mice, in which deletion of one copy of Gfi1 produces a normal phenotype, heterozygous mutations of GFI1 appear to cause disease in humans. We therefore measured the transcriptional consequences of the mutations in transient transfection of NIH3T3 cells, which do not express GFI1. Compared to cDNA expression of wild-type protein and a negative control peptide with a deletion of the essential N-terminal SNAG domain 10 , N382S abolished and K403R diminished repressor activity on a synthetic dimerized Gfi1-binding site fused to a herpes simplex virus (HSV) thymidine kinase (TK) promoter driving a chloramphenicol acetyl transferase (CAT) reporter (Fig. 2a) . Both mutations acted in a dominant negative manner when expressed competitively with the wildtype protein. HEK293T cells offer confirmatory results using a cytomegalovirus immediate early promoter (data not shown), which is also responsive to Gfi1 repression 11 The fifth zinc finger residue Asn382 contacts an adenine nucleotide through the minor groove of the Gfi1 DNA-binding site 11 . The sixth zinc finger, containing Lys403, does not contribute to sequence-specific DNA binding 10 . In an electrophoretic mobility shift assay (EMSA) using in vitro synthesized proteins, the N382S mutation abolished recognition of a consensus binding site (Fig. 2b) , but the K403R mutation had no effect (data not shown). N382S probably acts in a dominant negative manner by preserving interaction with other components of the transcriptional machinery but losing DNA-binding ability. The phenotypically milder K403R mutation could achieve a dominant negative effect by maintaining DNA binding but failing to associate with another factor, similar to the mechanism by which mutations of GATA1 cause thrombocytopenia, in which disruption of a zinc finger not involved in DNA binding blocks association with co-activator FOG 12 . Alternatively, our preliminary data (R.E.P. and M.H., unpublished data) suggest that Lys403 may be a site of addition of the small ubiquitin-related modifier SUMO.
The variability of neutropenia between the two pedigrees probably results from the severity of the effect of the two different mutations on Gfi1 transcriptional repressor activity. The variability of phenotype between the father and his two affected sons in the family with the N382S substitution may arise, in part, from an increase in the number of indistinctly differentiated myeloid cells that (at least with the deficient mice) occurs with aging. Alternatively, the father could be a statistical outlier representing an ascertainment bias in which only more mildly affected individuals will live to a 
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Proband Mother reproductive age. We were able to exclude two other possible explanations. The father's milder phenotype is not the result of mosaicism, as DNA from purified neutrophils or monocytes and from cultured erythroid colonies showed that all subclones possessed the mutation (data not shown). He has also not acquired mutations in the gene encoding the G-CSF receptor (data not shown), which is not uncommon in SCN 13 . We hypothesized that GFI1 represses ELA2, thus linking mutations in the two genes to a common phenotype. As a test, we carried out chromatin immunoprecipitation (ChIP) analysis. ELA2 is expressed in promyelocytes but not in differentiated granulocytes. We crosslinked DNA-bound protein in vivo in human KG-1 and U937 promyelocytes and, as a negative control, Jurkat T cells (all three cells express GFI1, but only the first two express ELA2 (ref. 14) , as the ELA2 chromatin is closed in lymphocytes). Two different antibodies immunoprecipitate GFI1-associated genes from chromatin. ELA2-specific PCR of a 3-kb upstream fragment confirmed Gfi1 binding in KG-1 and U937 cells but not in Jurkat cells (Fig. 3a) . We identified nine potential Gfi1-binding sites in this 3-kb upstream ELA2 promoter region. We tested each one and confirmed that two, -2,714 to -2,740 (Fig. 3b) and -336 to -362 (data not shown), are recognized by Gfi1 in EMSA, whereas an A-T rich element in ELA2 at -300 to -326 serves as a negative control (Fig. 3b) . Both the -2,714 to -2,740 (Fig. 3c) and the -336 to -362 (data not shown) binding sites, but not the -300 to -326 negative control (data not shown), functioned as repressor elements when fused to a TK promoter driving a CAT reporter in a transient transfection assay of Gfi1 in NIH3T3 cells. Concordantly, ELA2 expression is upregulated in the bone marrow of gene-targeted mice 2 .
To determine if ELA2 expression is similarly increased in vivo in humans with mutations in GFI1, we carried out two experiments. First, we measured neutrophil elastase enzymatic activity in extracts of peripheral mononuclear cells. To avoid confounding effects of treatment with G-CSF, we measured the activity in the cells of the father in the pedigree with the N382S substitution, who is not receiving G-CSF therapy. Neutrophil elastase activity in his cells was 2.33 times higher than the mean activity in two normal controls. Second, we measured ELA2 expression by RT-PCR. To avoid both confounding effects of G-CSF treatment and unscheduled bone marrow aspiration, we did these studies in non-erythroid colonies differentiated in vitro from peripheral blood obtained from the three-year-old son in the pedigree with the N382S substitution. Compared with his mother, and in contrast to expression of GAPD as an internal control, ELA2 transcription was higher. These results independently show that mutations in GFI1 cause overexpression of ELA2.
The identification of mutations in GFI1 that lead to SCN and other recent results place the effects of the SCN-causing ELA2 mutations in context. These ELA2 mutations do not consistently abrogate proteolytic activity, and their biochemical consequences are unclear 15 . Most commonly, these mutations delete the C-terminal extension of neutrophil elastase. Recent results show that mutations of AP3B1, encoding a subunit of an adapter protein complex required for post-translational trafficking from the Golgi to the lysosome, are the cause of a neutropenic variant 16 of Hermansky-Pudlak syndrome 17 and of canine cyclic hematopoiesis (K.F.B. and M.H., unpublished data) and that the C terminus of neutrophil elastase contains an adapter protein recognition signal required for lysosomal/granule localization. In the absence of either the adapter protein or this C-terminal signal, neutrophil elastase is mistrafficked, so that too much neutrophil elastase is delivered to particular subcellular compartments (membranes). We propose that the GFI1 mutations, by causing overexpression of neutrophil elastase, achieve a similar effect by generally increasing levels of neutrophil elastase in all subcellular locations, including those that accumulate too much enzyme as a result of mutations in normal post-translational trafficking pathways.
METHODS
Mutational analysis. We obtained informed consent from the subjects using protocols approved by the Institutional Review Boards of the University of Washington, University of Louisville and University of Crete. We amplified by PCR all exons and exon-intron junctions of GFI1 from genomic DNA extracted from peripheral blood and sequenced both strands with ABI Big Dye terminator chemistry using ABI capillary electrophoresis.
Colony formation assay. We overlaid peripheral blood on Ficoll-Hypaque (Beckman Coulter) density gradients. We removed interphase cells and cultured them at desired concentrations in methylcellulose supplemented with cytokines 18 for 14 d. To evaluate morphology, we picked non-erythroid colonies through a dissecting microscope and fixed and stained cytocentrifuge preparations.
Transient transfection assay. We used LipofectAMINE PLUS (GIBCO) to transiently cotransfect reporters (1 µg) into 10 6 NIH3T3 cells (ATCC) with Renilla luciferase vector pRL-TK (200 ng) as an internal control and harvested cell lysates 40 h later. We measured CAT and luciferase activities with the CAT ELISA Kit (Roche) and Dual-Luciferase Assay (Promega), respectively, normalizing CAT activity to luciferase activity. We expressed Gfi1 (amplified by RT-PCR from human bone marrow) and its derivatives from pCS2+ (100 ng in Fig. 3c and as noted in Fig. 2a) . We generated N382S, ∆SNAG and frameshift (+1 insertion in second codon) variants by oligonucleotide cassette mutagenesis. The TKCAT reporter contains the HSV minimal TK promoter directing expression of the CAT gene, whereas B30x2-TKCAT also contains dimerized high-affinity synthetic Gfi1 binding sites 10 ; both were gifts of P. Tsichlis (Sackler School, Tufts University). We generated TKCAT constructs containing different Gfi1 binding sites or control sites as follows: we excised the two B30 boxes by BglII/BamHI digestion, Klenow polishing, CIP dephosphorylation and ligation of double-stranded T4-kinased oligonucleotides. We immunoblotted cell extracts using nitrocellulose electroblotting and used goat monoclonal antibody against Gfi1 N-20 (Santa Cruz) and mouse monoclonal antibody against GAPDH (Research Diagnostics) for detection with the ECL system (Amersham).
EMSA. For Gfi1 synthesis, we used the TnT coupled transcription/translation system (Promega) with the expression vectors' SP6 promoter. We labeled double-stranded oligonucleotides with 5′-32 P using T4 kinase. The binding reaction mixture (10 µl final volume) contained labeled probes (2,000 cpm) in binding buffer (10 mM Tris-HCl, pH 7.5, 50 mM NaCl, 1 mM MgCl 2 , 1 mM ZnSO 4 , 0.5 mM dithiothreitol, 0.5 mM EDTA, 10% glycerol, 0.05% Nonidet P-40), 1 µg poly (dI-dC) and 2% of the in vitro translated protein (1 µl). The binding reactions were incubated for 20 min at room temperature. We added 200 ng antibody against Gfi1 N-20 for supershift. Probe sequences are available on request.
ChIP assay. We carried out ChIP as described 19 with the following modifications. We fixed 200-ml volumes of KG-1, U937 and Jurkat (2 × 10 8 ) cells (ATCC) with 1% formaldehyde for 10 min at 37 °C and then quenched the reaction with 0.125 M glycine. Sonication of cells (Fisher Scientific Ultrasonic Dismembrator Model 500) in 1× RIPA buffer (containing proteinase inhibitors) on ice generated soluble chromatin complexes with DNA fragment length <3 kb. Each reaction contained the equivalent of ∼10 7 cells (1.5 ml soluble chromatin) and either 15 µl antibody against Gfi1 N-20 (antibody 1) or a 1:500 dilution of rabbit antibody to amino acids 12-26 of GFI 10 (custom raised by Sigma Genosys; antibody 2). About 2 ng of immunoprecipitated DNA served as template in each reaction in a total volume of 20 µl and corresponded to about 1/10,000 to 1/20,000 of the genomic DNA isolated from 1.5 ml of soluble chromatin. We did experiments with antibody 1 and antibody 2 in triplicate and duplicate, respectively, with representative results shown.
Neutrophil elastase activity assay. We measured neutrophil elastase activity in extracts of 10 5 mononuclear cells from freshly drawn peripheral blood purified on Ficoll-Hypaque density gradients spectrophotometrically on the specific substrate suc-Ala-Ala-Ala-pNa as described 15 .
RT-PCR. We isolated total RNA from 4 × 10 3 cells from pooled non-erythroid colonies formed from peripheral blood (as described above) from the indicated individual using the QIAamp RNA Blood Mini-kit (Qiagen). Two step RT-PCR used the TaqMan Gold RT-PCR kit (ABI). We carried out semiquantitative expression analysis of ELA2 using three different specific human primer pairs and found consistent results with both random or oligo(dT) primed RNA. Primer sequences are available on request.
